547 related articles for article (PubMed ID: 22895942)
1. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.
Gluud LL; Krag A
Cochrane Database Syst Rev; 2012 Aug; (8):CD004544. PubMed ID: 22895942
[TBL] [Abstract][Full Text] [Related]
2. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.
Vadera S; Yong CWK; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012673. PubMed ID: 31220333
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension.
Ríos Castellanos E; Seron P; Gisbert JP; Bonfill Cosp X
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010180. PubMed ID: 25966446
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
[TBL] [Abstract][Full Text] [Related]
6. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
Roccarina D; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Benmassaoud A; Plaz Torres MC; Iogna Prat L; Csenar M; Arunan S; Begum T; Milne EJ; Tapp M; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013121. PubMed ID: 33822357
[TBL] [Abstract][Full Text] [Related]
7. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
[TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011573. PubMed ID: 32133620
[TBL] [Abstract][Full Text] [Related]
9. Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
Gana JC; Cifuentes LI; Gattini D; Villarroel Del Pino LA; Peña A; Torres-Robles R
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD010546. PubMed ID: 31550050
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding.
Khuroo MS; Khuroo NS; Farahat KL; Khuroo YS; Sofi AA; Dahab ST
Aliment Pharmacol Ther; 2005 Feb; 21(4):347-61. PubMed ID: 15709985
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011973. PubMed ID: 33498095
[TBL] [Abstract][Full Text] [Related]
12. Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011659. PubMed ID: 31922266
[TBL] [Abstract][Full Text] [Related]
13. Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
Gana JC; Cifuentes LI; Gattini D; Torres-Robles R
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011803. PubMed ID: 33164205
[TBL] [Abstract][Full Text] [Related]
14. Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
Roberts D; Best LM; Freeman SC; Sutton AJ; Cooper NJ; Arunan S; Begum T; Williams NR; Walshaw D; Milne EJ; Tapp M; Csenar M; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013155. PubMed ID: 33837526
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices.
Thiele M; Krag A; Rohde U; Gluud LL
Aliment Pharmacol Ther; 2012 May; 35(10):1155-65. PubMed ID: 22449261
[TBL] [Abstract][Full Text] [Related]
16. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
[TBL] [Abstract][Full Text] [Related]
17. Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials.
Gluud LL; Klingenberg S; Nikolova D; Gluud C
Am J Gastroenterol; 2007 Dec; 102(12):2842-8; quiz 2841, 2849. PubMed ID: 18042114
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices.
Gluud LL; Langholz E; Krag A
Aliment Pharmacol Ther; 2010 Oct; 32(7):859-71. PubMed ID: 20839387
[TBL] [Abstract][Full Text] [Related]
19. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
20. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
